AnaptysBio, Inc. (ANAB)
NASDAQ·Healthcare·Biotechnology
$54.16
-1.83%
Mkt Cap $1.68B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (31 analysts)
$73.67
Range $50.00 – $90.00
Implied Upside
+36.0%
Consensus $73.67 vs current $54.16
NASDAQ·Healthcare·Biotechnology
$54.16
-1.83%
Mkt Cap $1.68B
Buy
11
Hold
0
Sell
0
Price Target (31 analysts)
$73.67
Range $50.00 – $90.00
+36.0%
Consensus $73.67 vs current $54.16